Evidence map›Paper›PMID 27695002›Full record

ArticleNature immunology2016

Suppression by T

Peter T Sage, Noga Ron-Harel, Vikram R Juneja, Debattama R Sen, Seth Maleri, Waradon Sungnak, Vijay K Kuchroo, W Nicholas Haining, Nicolas Chevrier, Marcia Haigis and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 228 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Peter T SageDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Noga Ron-HarelDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Vikram R JunejaDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Debattama R SenDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-0947-8284
Seth MaleriDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Waradon SungnakEvergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
Vijay K KuchrooEvergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
W Nicholas HainingDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Nicolas ChevrierFAS Center for Systems Biology, Harvard University, Cambridge, Massachusetts, USA.
Marcia HaigisDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Arlene H SharpeDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Brigham and Women's Hospital · USHarvard University · USBroad Institute · USDana-Farber Cancer Institute · US

Funding

Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BLAZAR, BRUCE R · 2003 to 2023
$42.5M
The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupusP01AI065687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SHARPE, ARLENE H. · 2006 to 2016
$14.7M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
IN VIVO ROLE OF CTLA-4 IN COSTIMULATION AND AUTOIMMUNITYR01AI040614 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 1997 to 2018
$6.3M
In Vivo Function of the B7 Family of CostimulatorsR37AI038310 · NIAID · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2006 to 2015
$4.1M
NHLBI NIH HHS T32 HL007627NIAID NIH HHS P01 AI056299NIAID NIH HHS P01 AI065687NIAID NIH HHS R01 AI040614NIAID NIH HHS R37 AI038310
6 · The paper itself

Abstract

Follicular regulatory T cells (T

Indexed as

Immune ToleranceAnimalsAntibody FormationB-Lymphocyte SubsetsCells, CulturedEpigenesis, GeneticForkhead Transcription FactorsGerminal CenterInterleukin-21Interleukin-21 Receptor alpha SubunitInterleukinsMiceMice, Inbred C57BLMice, KnockoutT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, mouseIl21r protein, mouseInterleukin-21Interleukin-21 Receptor alpha SubunitInterleukins

Identifiers

PMID27695002
PMCPMC5502675
OpenAlexW2529255372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.